Breast cancer (BC) is the most common malignancy among women, with incidence rates even higher than for lung cancer [1], and it is generally divided into triple-negative breast cancer (TNBC), human epidermal growth factor receptor 2 (HER2) positive, and hormone receptor-positive (HR+). This evidence concerns the gene ERBB2 and breast cancer.